Incidence of Heart Failure or Cardiomyopathy After Adjuvant Trastuzumab Therapy for Breast Cancer

Study Questions:

What is the incidence of heart failure (HF) or cardiomyopathy (CM) after trastuzumab therapy for breast cancer?